Note: Ingredients listed on restricted chemical lists
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
≥25
EC/CAS
200-857-2/75-28-5
Name of the chemical
iso-Butan, enthält 0,1% Butadien
Concentration
≥10
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
<0,025
General Information
Version
9.0
Revision date
2025-01-10
Product name
Plasterboard Adhesive Foam Gen
supplier name
Soudal N.V
Emergency telephone
+32 70 245 245
Icons in SDS
Company Information
company name
Soudal N.V
e-mail address of the competent person responsible for the Safety Data Sheet
sds@soudal.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H222, H229, H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H222
Extremely flammable aerosol
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
Pressurised container: May burst if heated. Extremely flammable aerosol. Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled
Hazard pictograms
GHS02 GHS07 GHS08
Signal word
Danger
Contains
polymethylene polyphenyl isocyanate;reaction products of phosphoryl trichloride and 2- methyloxirane
Hazard statements
H222 - Extremely flammable aerosol. H229 - Pressurised container: May burst if heated. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P211 - Do not spray on an open flame or other ignition source. P251 - Do not pierce or burn, even after use. P308+P313 - IF exposed or concerned: Get medical advice/attention. P405 - Store locked up. P410+P412 - Protect from sunlight. Do not expose to temperatures exceeding 50°C/122°F. P501 - Dispose of contents, container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Additional information
Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to standard EN 14387) is used. As from 24 August 2023 adequate training is required before industrial or professional use.
2.3 Other hazards
The product does not meet the PBT and vPvB classification criteria Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) meeting the PBT criteria of REACH octamethylcyclotetrasiloxane; [D4] (556-67-2)(¹) regulation, in accordance with Annex XIII Substance(s) meeting the vPvB criteria of REACH octamethylcyclotetrasiloxane; [D4] (556-67-2)(¹) regulation, in accordance with Annex XIII Substance(s) not meeting the PBT criteria of REACH dimethyl ether (115-10-6), propane (74-98-6), isobutane (75-28-5), polymethylene regulation, in accordance with Annex XIII polyphenyl isocyanate (9016-87-9) Substance(s) not meeting the vPvB criteria of REACH dimethyl ether (115-10-6), propane (74-98-6), isobutane (75-28-5), polymethylene regulation, in accordance with Annex XIII polyphenyl isocyanate (9016-87-9) (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in octamethylcyclotetrasiloxane; [D4] (556-67-2)(¹) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Aerosol, Category 1 H222;H229 Acute toxicity (inhalation:dust,mist) Category 4 H332 Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Carcinogenicity, Category 2 H351 Specific target organ toxicity – Single exposure, Category 3, H335 Respiratory tract irritation Specific target organ toxicity – Repeated exposure, Category 2 H373 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Pressurised container: May burst if heated. Extremely flammable aerosol. Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.